Skip to main content
    S

    Sana Biotechnology Inc (SANA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.41
    -0.21 (-8.02%)

    Market Cap: $697.51M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    52%(12/23)
    Avg Surprise
    -27.15%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.13
    Range$-0.19 - $-0.10
    4 analysts
    EPS Revisions
    2
    0
    7d
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.12-8.3%
    60d ago$-0.12-8.3%
    30d ago$-0.12-9.8%
    7d ago$-0.12-9.8%
    Current$-0.13
    Revenue Consensus
    $0
    Range$0 - $0
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.19
    Range$-0.31 - $-0.08
    4 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.19---
    Sep 26EST
    		-$-0.13---
    Jun 26
    Reported Aug 11
    		$-0.13$-0.15+13.33%Beat+18.8%
    Mar 26
    Reported May 11
    		$-0.14$-0.15+6.67%Beat+30.0%
    Dec 25
    Reported Mar 3
    		$-0.16$-0.14-10.80%Miss+30.4%
    Sep 25
    Reported Nov 6
    		$-0.15$-0.19+21.05%Beat+44.4%
    Jun 25
    Reported Aug 11
    		$-0.16$-0.21+23.81%Beat+50.0%
    Mar 25
    Reported May 8
    		$-0.20$-0.20+0.00%Beat+37.5%
    Dec 24
    Reported Mar 17
    		$-0.23$-0.24+5.27%Beat+43.9%
    Sep 24
    Reported Nov 8
    		$-0.27$-0.27+0.00%Beat+34.1%
    Jun 24
    Reported Aug 8
    		$-0.32$-0.24-33.33%Miss+45.8%
    Mar 24
    Reported May 8
    		$-0.32$-0.22-45.45%Miss+25.6%
    Dec 23
    Reported Feb 29
    		$-0.41$-0.38-7.89%Miss-7.9%
    Sep 23
    Reported Nov 8
    		$-0.41$-0.45+8.89%Beat+14.6%
    Jun 23
    Reported Aug 3
    		$-0.59$-0.43-37.21%Miss-25.5%
    Mar 23
    Reported May 8
    		$-0.43$-0.37-16.22%Miss+8.5%
    Dec 22
    Reported Mar 16
    		$-0.38$-0.51+25.49%Beat+36.7%
    Sep 22
    Reported Nov 2
    		$-0.48$-0.39-23.08%Miss-29.7%
    Jun 22
    Reported Aug 4
    		$-0.47$-0.46-2.17%Miss-46.9%
    Mar 22
    Reported May 10
    		$-0.47$-0.38-23.68%Miss-62.1%
    Dec 21
    Reported Mar 16
    		$-0.60$-0.56-7.14%Miss+79.9%
    Sep 21
    Reported Nov 8
    		$-0.37$-0.50+26.00%Beat+92.5%
    Jun 21
    Reported Aug 4
    		$-0.32$-0.45+28.89%Beat-
    Mar 21
    Reported May 5
    		$-0.29$-0.58+50.00%Beat-
    Dec 20
    Reported Feb 5
    		$-2.98$-0.41-626.83%Miss-
    Sep 19
    Reported Dec 31
    		$-4.92$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-4.16EV/EBITDAN/A
    Price/FCF-5.28xFCF Yield-18.95%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-152.90%ROIC-56.35%
    Financial Health
    Debt/Equity0.97xInterest CoverageN/A
    Current Ratio1.38xQuick Ratio1.38x
    Trading Statistics
    Beta2.19Avg Volume4.03M
    52-Week High$5.9052-Week Low$2.32

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$2.77
    SMA 20$2.90
    SMA 50$3.36
    SMA 200$3.52
    EMA 10$2.74
    EMA 20$2.90
    EMA 50$3.17
    EMA 200$3.40

    MACD

    Line: -0.21Signal: -0.18Hist: -0.02

    ADX

    ADX: 26.3+DI: 11.8-DI: 34.1

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$2.81

    Bollinger Bands

    Upper Band$3.30
    Lower Band$2.51
    %B Position2726%(Upper)
    Band Width-0.12

    RSI (14-Day)

    Oversold
    25.6

    Momentum Oscillators

    Stoch %K9.5
    Stoch %D12.2
    Williams %R-94.2
    ROC (10d)-17.2%
    Momentum-0.50
    CCI (20d)-228.7
    MFI (14d)12.0

    Volatility Measures

    ATR (14d)$0.19(8.0%)
    StdDev (20d)0.20
    Hist Vol65.3%(High)

    Volume Flow

    VWAP$2.47
    OBV-65.9M
    AD Line-120.5M
    CMF (20d)-0.199

    Volume Metrics

    Avg Vol (20d)4.2M
    Vol Ratio1.2x
    VWMA (20d)$2.92

    Pivot Points

    R3$2.91
    R2$2.84
    R1$2.73
    Pivot Point$2.66
    S1$2.55
    S2$2.48
    S3$2.37

    Advanced Oscillators

    TSI-32.06
    Ultimate Osc27.9
    KST-196.18

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$15.28M$0$0$0$0$0
    Cost of Revenue$0$0$3.05M$0$0$0$7.64M$0$0$0$7.54M$0
    Gross Profit$0$0$-3,053,000$0$0$0$7.64M$0$0$0$-7,541,000$0
    Operating Expenses$65.42M$48.61M$61.20M$43.52M$94.97M$50.63M$50.87M$61.76M$49.37M$110.72M$90.62M$2.18M
    R&D$54.64M$37.15M$49.01M$33.23M$40.02M$39.15M$31.70M$47.71M$32.93M$94.45M$62.82M$-17,002,000
    SG&A$10.78M$11.46M$12.19M$10.29M$10.34M$11.48M$17.28M$14.05M$16.44M$16.27M$20.78M$19.18M
    Operating Income$-65,420,000$-48,614,000$-61,199,000$-43,515,000$-94,975,000$-50,630,000$-50,866,000$-61,761,000$-49,372,000$-110,724,000$-90,619,000$-2,181,000
    Interest Income$1.13M$951,000$1.28M$1.00M$577,000$992,000$1.66M$2.58M$3.20M$3.03M$2.73M$2.86M
    Interest Expense$0$0$0$0$0$0$0$0$919,000$0$0$0
    Income Before Tax$-63,635,000$-47,210,000$-61,130,000$-42,152,000$-93,800,000$-49,389,000$-48,854,000$-59,924,000$-50,291,000$-107,690,000$-88,164,000$984,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-63,635,000$-47,210,000$-58,825,000$-42,152,000$-93,800,000$-49,389,000$-49,069,000$-59,924,000$-50,291,000$-107,475,000$-88,117,000$984,000
    EBITDA$-62,530,000$-45,770,000$-58,146,000$-39,964,000$-91,520,000$-46,732,000$-47,064,000$-58,446,000$-49,598,000$-106,978,000$-86,369,000$2.62M
    EBIT$-64,764,000$-48,161,000$-61,199,000$-43,155,000$-94,377,000$-50,381,000$-50,866,000$-62,503,000$-53,493,000$-110,724,000$-90,619,000$-1,878,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SANA

    News

    Form 4 Sana Biotechnology Inc For: 11 October By Investing.com

    This article announces the filing of Form 4 for Sana Biotechnology Inc. on October 11th. It provides basic stock market data for SANA and other indices, commodities, and bonds...

    Investing.com Australia•10/11/26•Neutral

    Form 4 Sana Biotechnology Inc For: 11 October By Investing.com

    This article from Investing.com reports on a Form 4 filing for Sana Biotechnology Inc. on October 11. It's a brief announcement providing specific financial regulatory information. The core content is the Form 4 details...

    Investing.com South Africa•10/11/26•Neutral

    Form 4 Sana Biotechnology Inc For: 11 October By Investing.com

    This article from Investing.com reports on a Form 4 filing for Sana Biotechnology Inc. dated October 11. It's a very brief notice...

    Investing.com Nigeria•10/11/26•Neutral

    Form 4 Sana Biotechnology Inc For: 11 October By Investing.com

    This article announces the filing of Form 4 by Sana Biotechnology Inc. on October 11. It provides no further details about the content of the Form 4. The page appears to be a placeholder or a very brief notice from...

    Investing.com UK•10/11/26•Neutral

    Sana Biotechnology, Inc. (SANA) Stock Price, News, Quote & History

    This page provides comprehensive financial information for Sana Biotechnology, Inc. (SANA), including its current stock price, real-time quotes, and key market data. It also offers access to news, charts...

    Yahoo! Finance Canada•10/3/26•Neutral

    SANA Valuation and Fair Value

    P/E
    -4.2x
    P/FCF
    -5.3x
    P/B
    4.6x
    See GNG's fair value

    SANA Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -56.4%
    ROE
    -152.9%
    FCF yield
    -19.0%

    SANA Competitors

    CompanyTicker
    Verastem IncVSTM
    Annexon IncANNX
    Adlai Nortye Ltd. American Depositary SharesANL
    Gyre Therapeutics Inc.GYRE
    Collegium Pharmaceutical IncCOLL
    MiMedx Group IncMDXG
    Immix Biopharma IncIMMX
    Design Therapeutics IncDSGN

    Sector: Healthcare

    SANA Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    7.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.13
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    2 up, 1 down

    Frequently Asked Questions About SANA

    Does SANA pay dividends?

    Sana Biotechnology Inc (SANA) does not currently pay a regular dividend.

    What is SANA's market cap?

    Sana Biotechnology Inc (SANA) has a market capitalization of $697.51M with a current stock price of $2.41.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In